Chemistry:Propylphenidine
From HandWiki
Propylphenidine is a compound which has been sold as a designer drug, first identified in Australia in 2023. It is unclear what kind of activity it has, as it is claimed to be a stimulant in a patent along with related compounds such as phenylpropylaminopentane, but other structurally similar compounds such as ephenidine and isophenidine are dissociative anesthetic drugs, so it may produce either kind of activity or perhaps a mixture of both.[1][2][3]
Legal Status
In Australia, the Therapeutic Goods Administration decided to include propylphenidine as a Prohibited substance (Schedule 9) within the Standard for the Uniform Scheduling of Medicines and Poisons alongside four other phenidine analogs on 1 October 2024.[4]
See also
References
- ↑ Knoll J, Simay A, Szinnyei E, Somfai E, Torok Z, Mozsolits K, Bergmann J, "Psychostimulant agent", US patent 5220068, issued 15 June 1993
- ↑ "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Testing and Analysis 6 (7–8): 614–632. July–August 2014. doi:10.1002/dta.1620. PMID 24678061.
- ↑ "Identification of three unexpected new psychoactive substances at an Australian drug checking service". Drug Testing and Analysis 16 (10): 1144–1154. January 2024. doi:10.1002/dta.3637. PMID 38205685.
- ↑ "Notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #44, ACCS #38, Joint ACMS-ACCS #36". 27 September 2024. https://www.tga.gov.au/resources/publication/scheduling-decisions-final/notice-final-decision-amend-or-not-amend-current-poisons-standard-acms-44-accs-38-joint-acms-accs-36.
 |  |
